Analytical Data
-
Gene name
IER2
- Application
-
Alternative Names
ETR101; Immediate early response gene 2 protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BTL4
-
Expression Region
Met1~Phe223
-
Molecular Weight
26kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IER2 (Immediate Early Response 2) is a gene that encodes a protein implicated in various cellular processes, including stress response, growth regulation, and apoptosis. Research into IER2 recombinant proteins gained momentum due to the protein's potential role in cancer biology and neurodegenerative diseases. Its expression is often upregulated in response to extracellular stimuli, suggesting a regulatory function in cellular signaling pathways. The study of IER2 proteins, especially their recombinant forms, enables researchers to investigate their structural and functional properties in vitro, as well as their interactions with other cellular molecules. Understanding IER2's mechanism of action could reveal insights into tumor progression and resistance to therapies, making it a target of interest in drug discovery. Moreover, recombinant IER2 proteins can be utilized in the development of antibodies and the study of post-translational modifications, further expanding their applicability in both basic and applied biomedical research.
